Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Receivables (2016 - 2026)

Rockwell Medical filings provide 16 years of Receivables readings, the most recent being $8.1 million for Q4 2025.

  • On a quarterly basis, Receivables fell 1.79% to $8.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.1 million, a 1.79% decrease, with the full-year FY2025 number at $8.1 million, down 1.79% from a year prior.
  • Receivables hit $8.1 million in Q4 2025 for Rockwell Medical, down from $8.3 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $16.2 million in Q2 2022 to a low of $5.4 million in Q2 2023.
  • Median Receivables over the past 5 years was $10.2 million (2021), compared with a mean of $10.2 million.
  • Biggest five-year swings in Receivables: tumbled 66.56% in 2023 and later skyrocketed 100.33% in 2024.
  • Rockwell Medical's Receivables stood at $11.8 million in 2021, then plummeted by 47.07% to $6.3 million in 2022, then soared by 74.17% to $10.9 million in 2023, then dropped by 23.94% to $8.3 million in 2024, then dropped by 1.79% to $8.1 million in 2025.
  • The last three reported values for Receivables were $8.1 million (Q4 2025), $8.3 million (Q3 2025), and $8.1 million (Q2 2025) per Business Quant data.